Current status of radioimmunodetection Journal Article


Authors: Larson, S. M.; Divgi, C.; Scott, A.; Daghighian, F.; Macapinlac, H.; Welt, S.
Article Title: Current status of radioimmunodetection
Abstract: Radioimmunodetection is a nuclear medicine technique that depends on in vivo detection of localization of antibodies and antibody forms carrying radioactivity for the purpose of diagnosis in patients with cancer. Current methods take advantage of tracers suitable for high resolution γ-camera imaging, such as 99mTc and 111In, for common tumors, such as colon and lung cancers. In addition, tracers such as 125I have been used for the intraoperative detection of metastatic deposits. These methods detect from 75 to 90% of metastatic deposits with high specificity, and typically contribute important diagnostic information, even in 25-40% of patients with occult disease. © 1994.
Keywords: major clinical study; conference paper; technetium 99m; sensitivity and specificity; radiopharmaceuticals; neoplasms; metastasis; lung cancer; monoclonal antibody; indium radioisotopes; iodine 131; iodine radioisotopes; colon cancer; neoplasm metastasis; indium 111; clinical trials; organotechnetium compounds; tomography, emission-computed, single-photon; occult cancer; radioimmunodetection; immunoscintigraphy; cancer; human; male; female
Journal Title: Nuclear Medicine and Biology
Volume: 21
Issue: 5
ISSN: 0969-8051
Publisher: Elsevier Science Inc.  
Date Published: 1994-07-01
Start Page: 721
End Page: 729
Language: English
DOI: 10.1016/0969-8051(94)90043-4
PROVIDER: scopus
PUBMED: 9241648
DOI/URL:
Notes: Export Date: 14 January 2019 -- Article -- CODEN: NMBIE C2 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Chaitanya Divgi
    163 Divgi
  2. Steven M Larson
    959 Larson
  3. Sydney   Welt
    98 Welt
  4. Andrew M. Scott
    62 Scott